Lathrop Investment Management Co. raised its position in shares of Danaher Corporation (NYSE:DHR – Free Report) by 12.4% in the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 28,195 shares of the conglomerate’s stock after buying an additional 3,112 shares during the period. Lathrop Investment Management Co.’s holdings in Danaher were worth $6,454,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of the company. Enterprise Financial Services Corp boosted its position in shares of Danaher by 1.4% during the fourth quarter. Enterprise Financial Services Corp now owns 3,219 shares of the conglomerate’s stock worth $737,000 after buying an additional 46 shares during the period. Kennebec Savings Bank boosted its position in shares of Danaher by 1.4% during the fourth quarter. Kennebec Savings Bank now owns 3,348 shares of the conglomerate’s stock worth $766,000 after buying an additional 46 shares during the period. Revolve Wealth Partners LLC boosted its position in shares of Danaher by 2.6% during the fourth quarter. Revolve Wealth Partners LLC now owns 1,870 shares of the conglomerate’s stock worth $428,000 after buying an additional 47 shares during the period. High Note Wealth LLC boosted its position in shares of Danaher by 19.2% during the fourth quarter. High Note Wealth LLC now owns 292 shares of the conglomerate’s stock worth $67,000 after buying an additional 47 shares during the period. Finally, Kestra Private Wealth Services LLC boosted its stake in shares of Danaher by 0.3% in the third quarter. Kestra Private Wealth Services LLC now owns 15,421 shares of the conglomerate’s stock valued at $3,057,000 after purchasing an additional 48 shares during the period. 79.05% of the stock is currently owned by hedge funds and other institutional investors.
Danaher Trading Down 0.7%
NYSE:DHR opened at $172.12 on Friday. The stock has a 50-day simple moving average of $183.52 and a 200-day simple moving average of $208.73. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.52 and a current ratio of 1.87. Danaher Corporation has a 1 year low of $160.93 and a 1 year high of $242.80. The stock has a market cap of $121.82 billion, a P/E ratio of 33.29, a P/E/G ratio of 2.30 and a beta of 0.81.
Danaher Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, June 26th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.9%. Danaher’s payout ratio is 30.95%.
Analyst Ratings Changes
A number of brokerages recently weighed in on DHR. JPMorgan Chase & Co. dropped their price objective on shares of Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Morgan Stanley dropped their price objective on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating for the company in a report on Wednesday, April 22nd. Rothschild & Co Redburn set a $205.00 price objective on shares of Danaher in a report on Friday, April 17th. Deutsche Bank Aktiengesellschaft restated a “buy” rating on shares of Danaher in a report on Thursday, January 29th. Finally, TD Cowen reduced their price objective on Danaher from $245.00 to $240.00 and set a “buy” rating on the stock in a research note on Wednesday, April 22nd. Nineteen analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $238.65.
About Danaher
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Read More
- Five stocks we like better than Danaher
- Workday Validates AI Flywheel: Stock Price Recovery Begins
- HubSpot at 2019 Levels Is an Opportunity—Not a Warning
- Was Decker’s Double Beat a Bullish Signal—Or Mere HOKA’s-Pocus?
- Kiniksa Pharmaceuticals Still Has Room to Run After 100% Rally
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
